Guiding pluripotent stem cell therapies past the immune system
An immunological perspective is provided on how the breadth of rejection mechanisms that have been uncovered through decades of research and the relative simplicity of designing PSC immune evasion strategies to circumvent these mechanisms apply to the treatment of type 1 diabetes are discussed.